# Effect of folic acid and vitamin B12 plus rosuvastatin in the treatment of coronary heart disease combined with hyperlipidemia

**Authors:** Hao Wang, Tiezheng Wang

PMC · DOI: 10.3389/fcvm.2025.1604862 · 2025-07-30

## TL;DR

Adding folic acid and vitamin B12 to rosuvastatin improves heart function and lipid levels in patients with coronary heart disease and high cholesterol.

## Contribution

The study demonstrates that combining folic acid and vitamin B12 with rosuvastatin yields better outcomes than rosuvastatin alone.

## Key findings

- The study group showed greater improvement in cardiac function and lipid levels compared to the control group.
- Folic acid and vitamin B12 combination reduced homocysteine and inflammatory markers more effectively.
- No significant adverse reactions were observed in either group.

## Abstract

To explore the effect of folic acid and vitamin B12 plus rosuvastatin in treating coronary heart disease (CHD) complicated with hyperlipidemia.

One hundred CHD patients combined with hyperlipidemia admitted to our hospital from January 2022 to December 2023 were separated into study group as well as control group. The control group accepted rosuvastatin calcium tablets. The study group received rosuvastatin plus folic acid and vitamin B12. The cardiac function, blood lipid, plasma Hcy, folate and vitamin B12 levels, inflammation, clinical effect along with occurrence of adverse reactions were compared in 2 groups.

Compared to before therapy, LVEDD and LVESD levels were declined while LVEF level was elevated in 2 groups after therapy, TC, TG and LDL-C levels were declined while HDL-C level was elevated in 2 groups after therapy, plasma Hcy level was declined while folate and vitamin B12 levels were elevated in 2 groups after therapy, and IL-6, TNF-α along with CRP levels were declined in 2 groups after therapy. Compared to control group, the improvements of the above cardiac function indicators, blood lipid indexes, plasma Hcy, folate and vitamin B12 levels, serum inflammatory markers in the study group were more apparent, the total effective rate in the study group presented better. No difference was seen in the occurrence of adverse reactions between 2 groups.

Folic acid and vitamin B12 plus rosuvastatin can effectively improve cardiac function, blood lipid, inflammatory response, and has high safety in treating CHD complicated with hyperlipidemia.

## Linked entities

- **Chemicals:** folic acid (PubChem CID 135398658), vitamin B12 (PubChem CID 73415824), rosuvastatin (PubChem CID 446157), TC (PubChem CID 23957), TG (PubChem CID 2723601), Hcy (PubChem CID 91552), IL-6 (PubChem CID 165368475)
- **Diseases:** coronary heart disease (MONDO:0005010), hyperlipidemia (MONDO:0021187)

## Full-text entities

- **Genes:** TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, CRP (C-reactive protein) [NCBI Gene 1401] {aka PTX1}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}
- **Diseases:** abnormal lipid metabolism (MESH:D052439), Hyperlipidemia (MESH:D006949), Dyslipidemia (MESH:D050171), malignant tumors (MESH:D009369), angina pectoris (MESH:D000787), abnormal liver function and renal function (MESH:D003291), inflammatory damage (MESH:D018746), folate deficiency (MESH:C562799), platelet aggregation (MESH:D001791), autoimmune disease (MESH:D001327), chronic heart failure (MESH:D006333), dizziness (MESH:D004244), lipid (MESH:D011017), cardiovascular diseases (MESH:D002318), nausea and vomiting (MESH:D020250), thrombosis (MESH:D013927), Alzheimer's disease (MESH:D000544), palpitation (MESH:D006331), Metabolic abnormalities (MESH:D008659), gastrointestinal discomfort (MESH:D005767), CHD (MESH:D003327), cerebrovascular disease (MESH:D002561), inflammation (MESH:D007249), allergic reactions (MESH:D004342), atherosclerosis (MESH:D050197), stroke (MESH:D020521), coronary artery disease (MESH:D003324), cognitive impairment (MESH:D003072)
- **Chemicals:** Blood lipid (-), TG (MESH:D014280), Folic acid (MESH:D005492), vitamin B12 (MESH:D014805), nitric oxide (MESH:D009569), cholesterol (MESH:D002784), TG (MESH:D013866), lipid (MESH:D008055), free fatty acids (MESH:D005230), methionine (MESH:D008715), cysteine (MESH:D003545), TC (MESH:D013667), calcium (MESH:D002118), Rosuvastatin (MESH:D000068718), amino acid (MESH:D000596), Hcy (MESH:D006710), thymine (MESH:D013941), phospholipids (MESH:D010743), fatty acid (MESH:D005227), sulfur (MESH:D013455), methylmalonic acid (MESH:D008764)
- **Species:** Homo sapiens (human, species) [taxon 9606]

---
Source: https://tomesphere.com/paper/PMC12343501